Ei tietoja.
2026 Q1 -tulosraportti
Vain PDF
30 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 26.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·2 t sittenJust think how all the "pumpers" have been nagging about the big trigger in EAP and Fluidda over the last six months. "Fluidda's (on three patients) no consistent imaging diagnostic results were observed and no conclusions can be drawn." The EAP study (6 patients) also completely lacked effect value. Tolerance/tox was good.
2 t sittenDefinitley less (not worse but smaller n) efficacy data than what we hoped for. Still signs of efficacy. Moderately positive in my books but not the homerun some expected.
·4 t sittenWhat I like best about Cereno is that the company has gone from being a "story company" to having several concrete value drivers: CS1 is entering a global phase IIb study for pulmonary arterial hypertension (PAH), which is the most important value driver. Long-term data from the Expanded Access program continues to show good safety, which strengthens the case before phase IIb. Management actively participates in international partner conferences, including BIO 2026, with the stated goal of promoting partner discussions. If phase IIb is successful, a larger pharmaceutical company could come into play with a license or acquisition agreement. It is often this that creates the largest share price movements in biotech.
·15.6. · MuokattuSeriously, I said it on the way up a few days ago too... Can we try to have a sensible debate here instead of throwing insults and making nasty comments to each other? This applies to both those of us who think the price should be higher and those who think it should be lower. I asked a few days ago and I'm asking again. Can we agree that rNPV is a sensible model for clarifying what the company should be worth? If not, what alternative model do you suggest? If we agree on that, what assumptions do you think one should / should not take into account? As I wrote below, I have made a proposal for an rNPV calculator that is based on Edison's valuation. (disclaimer, I don't know their model and have used AI to create my model, it's probably not 100%, but let's discuss it so it gets better) Link to the calculator is here: https://claude.ai/public/artifacts/cdcb9883-3342-4f6e-a1e5-51f3ef25fd1a If we can discuss the different variables in such a valuation together, we should be able to get closer to an understanding of what we think the company should be worth and why we might disagree with the valuation. I believe it will give us all greater understanding, and better patience with others' viewpoints. Those who talk the price up or down without contributing to this can go take a hike for all I care. Then you are here to pump or dump and your opinion means absolutely nothing to me. Looking forward to responses, let the debate begin!
You are naive if you think that people like fjellexpression, gaziemille, or investorareboss use anything other than their gut feeling to ragebait full-time
15.6.So, how is the price development holding up guys?Those who only participate in the prediction contest, I think you shouldn't let them cross the offense threshold. Just ignore it if it doesn't mean anything to you anyway. As we said without inhibitions in the Jurassic period, when I was young and handsome: "Screw it!" (Now I'm just handsome (hehe) -NOT.) You asked: "How do you relate to and identify these historical turning points?" Answer 1. -I am in learning mode ALL THE TIME with a focus on knowing myself so I don't repeat old mistakes. It still fails quite often for me. Answer 2. At the same time, I am concerned with how all the other shareholders in a specific stock think. A kind of species identification of the "herd" that trades at any given time. Are they exposed to false narratives, e.g. -And how rational are they? Do they all think alike? etc. 3. I use wave analysis from mathematics: All complex wave movements with a known period, can be decomposed into a set of pure sine oscillations. The complex curve being analyzed can thus be recreated by summing the amplitudes from these sine waves. And then there is a basis for saying that "every time the derivative of the sine curve is 0, we have a turning point". Answer 4. -I think metaphorically. Symbolic thinking, analogies etc. I discovered metaphorical thinking in its depth during my BI studies, in the book Organisasjonbilder by G. Morgan. What he writes resonated strongly with my worldview and my understanding of my own - and not least others' - thinking. See ark.no/produkt/boker/fagboker/organisasjonsbilder-978820012728 Answer 5. Beyond this, I like to think about the sea and all the waves there. The closer you get, the better the small ripples on the sea surface are visible. -But if you get too close, you no longer see the swells. And if you want to understand the period of high and low tide, you have to take time to help. Answer 6. -Anyone who has read this far might think that "That was intense, everyone understands that". I hope so. So, a few words about my daily method in practice: I click the button for technical analysis, enter moving averages for 14, 30 and 90 days and RSI (14). The challenge then is to read the statistics correctly. For a more global perspective on trading, I suggest the website armstrongeconomics.com He is the great "Guru". Thanks for your attention! :-)- ·12.6.the skeptics are quiet, I thought the price would hit 1 before it came up again ?
@GrazieMille99 Do you know that CU data, fluidda readout shall be reported as well as FPI in phase 2B for CS1. In case of a positive outcome, it is likely to bounce up quite well. I don't think the company will have difficulty raising money regardless.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
30 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 t sittenJust think how all the "pumpers" have been nagging about the big trigger in EAP and Fluidda over the last six months. "Fluidda's (on three patients) no consistent imaging diagnostic results were observed and no conclusions can be drawn." The EAP study (6 patients) also completely lacked effect value. Tolerance/tox was good.2 t sittenDefinitley less (not worse but smaller n) efficacy data than what we hoped for. Still signs of efficacy. Moderately positive in my books but not the homerun some expected.
- ·4 t sittenWhat I like best about Cereno is that the company has gone from being a "story company" to having several concrete value drivers: CS1 is entering a global phase IIb study for pulmonary arterial hypertension (PAH), which is the most important value driver. Long-term data from the Expanded Access program continues to show good safety, which strengthens the case before phase IIb. Management actively participates in international partner conferences, including BIO 2026, with the stated goal of promoting partner discussions. If phase IIb is successful, a larger pharmaceutical company could come into play with a license or acquisition agreement. It is often this that creates the largest share price movements in biotech.
- ·15.6. · MuokattuSeriously, I said it on the way up a few days ago too... Can we try to have a sensible debate here instead of throwing insults and making nasty comments to each other? This applies to both those of us who think the price should be higher and those who think it should be lower. I asked a few days ago and I'm asking again. Can we agree that rNPV is a sensible model for clarifying what the company should be worth? If not, what alternative model do you suggest? If we agree on that, what assumptions do you think one should / should not take into account? As I wrote below, I have made a proposal for an rNPV calculator that is based on Edison's valuation. (disclaimer, I don't know their model and have used AI to create my model, it's probably not 100%, but let's discuss it so it gets better) Link to the calculator is here: https://claude.ai/public/artifacts/cdcb9883-3342-4f6e-a1e5-51f3ef25fd1a If we can discuss the different variables in such a valuation together, we should be able to get closer to an understanding of what we think the company should be worth and why we might disagree with the valuation. I believe it will give us all greater understanding, and better patience with others' viewpoints. Those who talk the price up or down without contributing to this can go take a hike for all I care. Then you are here to pump or dump and your opinion means absolutely nothing to me. Looking forward to responses, let the debate begin!You are naive if you think that people like fjellexpression, gaziemille, or investorareboss use anything other than their gut feeling to ragebait full-time
- 15.6.So, how is the price development holding up guys?Those who only participate in the prediction contest, I think you shouldn't let them cross the offense threshold. Just ignore it if it doesn't mean anything to you anyway. As we said without inhibitions in the Jurassic period, when I was young and handsome: "Screw it!" (Now I'm just handsome (hehe) -NOT.) You asked: "How do you relate to and identify these historical turning points?" Answer 1. -I am in learning mode ALL THE TIME with a focus on knowing myself so I don't repeat old mistakes. It still fails quite often for me. Answer 2. At the same time, I am concerned with how all the other shareholders in a specific stock think. A kind of species identification of the "herd" that trades at any given time. Are they exposed to false narratives, e.g. -And how rational are they? Do they all think alike? etc. 3. I use wave analysis from mathematics: All complex wave movements with a known period, can be decomposed into a set of pure sine oscillations. The complex curve being analyzed can thus be recreated by summing the amplitudes from these sine waves. And then there is a basis for saying that "every time the derivative of the sine curve is 0, we have a turning point". Answer 4. -I think metaphorically. Symbolic thinking, analogies etc. I discovered metaphorical thinking in its depth during my BI studies, in the book Organisasjonbilder by G. Morgan. What he writes resonated strongly with my worldview and my understanding of my own - and not least others' - thinking. See ark.no/produkt/boker/fagboker/organisasjonsbilder-978820012728 Answer 5. Beyond this, I like to think about the sea and all the waves there. The closer you get, the better the small ripples on the sea surface are visible. -But if you get too close, you no longer see the swells. And if you want to understand the period of high and low tide, you have to take time to help. Answer 6. -Anyone who has read this far might think that "That was intense, everyone understands that". I hope so. So, a few words about my daily method in practice: I click the button for technical analysis, enter moving averages for 14, 30 and 90 days and RSI (14). The challenge then is to read the statistics correctly. For a more global perspective on trading, I suggest the website armstrongeconomics.com He is the great "Guru". Thanks for your attention! :-)
- ·12.6.the skeptics are quiet, I thought the price would hit 1 before it came up again ?@GrazieMille99 Do you know that CU data, fluidda readout shall be reported as well as FPI in phase 2B for CS1. In case of a positive outcome, it is likely to bounce up quite well. I don't think the company will have difficulty raising money regardless.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 26.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
30 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 26.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 t sittenJust think how all the "pumpers" have been nagging about the big trigger in EAP and Fluidda over the last six months. "Fluidda's (on three patients) no consistent imaging diagnostic results were observed and no conclusions can be drawn." The EAP study (6 patients) also completely lacked effect value. Tolerance/tox was good.2 t sittenDefinitley less (not worse but smaller n) efficacy data than what we hoped for. Still signs of efficacy. Moderately positive in my books but not the homerun some expected.
- ·4 t sittenWhat I like best about Cereno is that the company has gone from being a "story company" to having several concrete value drivers: CS1 is entering a global phase IIb study for pulmonary arterial hypertension (PAH), which is the most important value driver. Long-term data from the Expanded Access program continues to show good safety, which strengthens the case before phase IIb. Management actively participates in international partner conferences, including BIO 2026, with the stated goal of promoting partner discussions. If phase IIb is successful, a larger pharmaceutical company could come into play with a license or acquisition agreement. It is often this that creates the largest share price movements in biotech.
- ·15.6. · MuokattuSeriously, I said it on the way up a few days ago too... Can we try to have a sensible debate here instead of throwing insults and making nasty comments to each other? This applies to both those of us who think the price should be higher and those who think it should be lower. I asked a few days ago and I'm asking again. Can we agree that rNPV is a sensible model for clarifying what the company should be worth? If not, what alternative model do you suggest? If we agree on that, what assumptions do you think one should / should not take into account? As I wrote below, I have made a proposal for an rNPV calculator that is based on Edison's valuation. (disclaimer, I don't know their model and have used AI to create my model, it's probably not 100%, but let's discuss it so it gets better) Link to the calculator is here: https://claude.ai/public/artifacts/cdcb9883-3342-4f6e-a1e5-51f3ef25fd1a If we can discuss the different variables in such a valuation together, we should be able to get closer to an understanding of what we think the company should be worth and why we might disagree with the valuation. I believe it will give us all greater understanding, and better patience with others' viewpoints. Those who talk the price up or down without contributing to this can go take a hike for all I care. Then you are here to pump or dump and your opinion means absolutely nothing to me. Looking forward to responses, let the debate begin!You are naive if you think that people like fjellexpression, gaziemille, or investorareboss use anything other than their gut feeling to ragebait full-time
- 15.6.So, how is the price development holding up guys?Those who only participate in the prediction contest, I think you shouldn't let them cross the offense threshold. Just ignore it if it doesn't mean anything to you anyway. As we said without inhibitions in the Jurassic period, when I was young and handsome: "Screw it!" (Now I'm just handsome (hehe) -NOT.) You asked: "How do you relate to and identify these historical turning points?" Answer 1. -I am in learning mode ALL THE TIME with a focus on knowing myself so I don't repeat old mistakes. It still fails quite often for me. Answer 2. At the same time, I am concerned with how all the other shareholders in a specific stock think. A kind of species identification of the "herd" that trades at any given time. Are they exposed to false narratives, e.g. -And how rational are they? Do they all think alike? etc. 3. I use wave analysis from mathematics: All complex wave movements with a known period, can be decomposed into a set of pure sine oscillations. The complex curve being analyzed can thus be recreated by summing the amplitudes from these sine waves. And then there is a basis for saying that "every time the derivative of the sine curve is 0, we have a turning point". Answer 4. -I think metaphorically. Symbolic thinking, analogies etc. I discovered metaphorical thinking in its depth during my BI studies, in the book Organisasjonbilder by G. Morgan. What he writes resonated strongly with my worldview and my understanding of my own - and not least others' - thinking. See ark.no/produkt/boker/fagboker/organisasjonsbilder-978820012728 Answer 5. Beyond this, I like to think about the sea and all the waves there. The closer you get, the better the small ripples on the sea surface are visible. -But if you get too close, you no longer see the swells. And if you want to understand the period of high and low tide, you have to take time to help. Answer 6. -Anyone who has read this far might think that "That was intense, everyone understands that". I hope so. So, a few words about my daily method in practice: I click the button for technical analysis, enter moving averages for 14, 30 and 90 days and RSI (14). The challenge then is to read the statistics correctly. For a more global perspective on trading, I suggest the website armstrongeconomics.com He is the great "Guru". Thanks for your attention! :-)
- ·12.6.the skeptics are quiet, I thought the price would hit 1 before it came up again ?@GrazieMille99 Do you know that CU data, fluidda readout shall be reported as well as FPI in phase 2B for CS1. In case of a positive outcome, it is likely to bounce up quite well. I don't think the company will have difficulty raising money regardless.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt